 |
The Journal of Neuroscience, February 11, 2004, 24(6):1521-1529; doi:10.1523/JNEUROSCI.4271-03.2004
Previous Article
Neurobiology of Disease
A1 Adenosine Receptor Upregulation and Activation Attenuates Neuroinflammation and Demyelination in a Model of Multiple Sclerosis
Shigeki Tsutsui,1
Jurgen Schnermann,3
Farshid Noorbakhsh,1
Scot Henry,1
V. Wee Yong,1
Brent W. Winston,2
Kenneth Warren,4 and
Christopher Power1
Departments of 1Clinical Neurosciences and 2 Critical Care Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada, 3National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-1370, and 4Department of Medicine, University of Alberta, Edmonton, Alberta T6G 2B7, Canada
The neuromodulator adenosine regulates immune activation and neuronal survival through specific G-protein-coupled receptors expressed on macrophages and neurons, including the A1 adenosine receptor (A1AR). Here we show that A1AR null (A1AR-/-) mice developed a severe progressive-relapsing form of experimental allergic encephalomyelitis (EAE) compared with their wild-type (A1AR+/+) littermates. Worsened demyelination, axonal injury, and enhanced activation of microglia/macrophages were observed in A1AR-/- animals. In addition, spinal cords from A1AR-/- mice demonstrated increased proinflammatory gene expression during EAE, whereas anti-inflammatory genes were suppressed compared with A1AR+/+ animals. Macrophages from A1AR-/- animals exhibited increased expression of the proinflammatory genes, interleukin-1 , and matrix metalloproteinase-12 on immune activation when matched with A1AR+/+ control cells. A1AR-/- macrophage-derived soluble factors caused significant oligodendrocyte cytotoxicity compared with wild-type controls. The A1AR was downregulated in microglia in A1AR+/+ mice during EAE accompanied by neuroinflammation, which recapitulated findings in multiple sclerosis (MS) patients. Caffeine treatment augmented A1AR expression on microglia, with ensuing reduction of EAE severity, which was further enhanced by concomitant treatment with the A1AR agonist, adenosine amine congener. Thus, modulation of neuroinflammation by the A1AR represents a novel mechanism that provides new therapeutic opportunities for MS and other demyelinating diseases.
Key words: EAE; cytokines; MMPs; demyelination; adenosine amine congener; caffeine
Received Sep 18, 2003;
revised December 15, 2003;
accepted December 15, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
F. Maingat, P. Vivithanaporn, Y. Zhu, A. Taylor, G. Baker, K. Pearson, and C. Power
Neurobehavioral Performance in Feline Immunodeficiency Virus Infection: Integrated Analysis of Viral Burden, Neuroinflammation, and Neuronal Injury in Cortex
J. Neurosci.,
July 1, 2009;
29(26):
8429 - 8437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K. Ellestad, S. Tsutsui, F. Noorbakhsh, K. G. Warren, V. W. Yong, Q. J. Pittman, and C. Power
Early Life Exposure to Lipopolysaccharide Suppresses Experimental Autoimmune Encephalomyelitis by Promoting Tolerogenic Dendritic Cells and Regulatory T Cells
J. Immunol.,
July 1, 2009;
183(1):
298 - 309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tsutsui, J. N. Hahn, T. A. Johnson, Z. Ali, and F. R. Jirik
Absence of the Cellular Prion Protein Exacerbates and Prolongs Neuroinflammation in Experimental Autoimmune Encephalomyelitis
Am. J. Pathol.,
October 1, 2008;
173(4):
1029 - 1041.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Mills, L. F. Thompson, C. Mueller, A. T. Waickman, S. Jalkanen, J. Niemela, L. Airas, and M. S. Bynoe
CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis
PNAS,
July 8, 2008;
105(27):
9325 - 9330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lauro, S. Di Angelantonio, R. Cipriani, F. Sobrero, L. Antonilli, V. Brusadin, D. Ragozzino, and C. Limatola
Activity of Adenosine Receptors Type 1 Is Required for CX3CL1-Mediated Neuroprotection and Neuromodulation in Hippocampal Neurons
J. Immunol.,
June 1, 2008;
180(11):
7590 - 7596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Johnson, S. Tsutsui, and F. R. Jirik
Antigen-Induced Pten Gene Deletion in T Cells Exacerbates Neuropathology in Experimental Autoimmune Encephalomyelitis
Am. J. Pathol.,
April 1, 2008;
172(4):
980 - 992.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tsutsui, D. Vergote, N. Shariat, K. Warren, S. S. G. Ferguson, and C. Power
Glucocorticoids regulate innate immunity in a model of multiple sclerosis: reciprocal interactions between the A1 adenosine receptor and {beta}-arrestin-1 in monocytoid cells
FASEB J,
March 1, 2008;
22(3):
786 - 796.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. van Marle, J. Antony, H. Ostermann, C. Dunham, T. Hunt, W. Halliday, F. Maingat, M. D. Urbanowski, T. Hobman, J. Peeling, et al.
West Nile Virus-Induced Neuroinflammation: Glial Infection and Capsid Protein-Mediated Neurovirulence
J. Virol.,
October 15, 2007;
81(20):
10933 - 10949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Afkhami-Goli, F. Noorbakhsh, A. J. Keller, N. Vergnolle, D. Westaway, J. H. Jhamandas, P. Andrade-Gordon, M. D. Hollenberg, H. Arab, R. H. Dyck, et al.
Proteinase-Activated Receptor-2 Exerts Protective and Pathogenic Cell Type-Specific Effects in Alzheimer's Disease
J. Immunol.,
October 15, 2007;
179(8):
5493 - 5503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Desrosiers, K. M. Cembrola, M. J. Fakir, L. A. Stephens, F. M. Jama, A. Shameli, W. Z. Mehal, P. Santamaria, and Y. Shi
Adenosine Deamination Sustains Dendritic Cell Activation in Inflammation
J. Immunol.,
August 1, 2007;
179(3):
1884 - 1892.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. H. Nemeth, D. Bleich, B. Csoka, P. Pacher, J. G. Mabley, L. Himer, E. S. Vizi, E. A. Deitch, C. Szabo, B. N. Cronstein, et al.
Adenosine receptor activation ameliorates type 1 diabetes
FASEB J,
August 1, 2007;
21(10):
2379 - 2388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Antony, K. K. Ellestad, R. Hammond, K. Imaizumi, F. Mallet, K. G. Warren, and C. Power
The Human Endogenous Retrovirus Envelope Glycoprotein, Syncytin-1, Regulates Neuroinflammation and Its Receptor Expression in Multiple Sclerosis: A Role for Endoplasmic Reticulum Chaperones in Astrocytes
J. Immunol.,
July 15, 2007;
179(2):
1210 - 1224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Jones, N. L. Barsby, E. A. Cohen, J. Holden, K. Harris, P. Dickie, J. Jhamandas, and C. Power
HIV-1 Vpr Causes Neuronal Apoptosis and In Vivo Neurodegeneration
J. Neurosci.,
April 4, 2007;
27(14):
3703 - 3711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Synowitz, R. Glass, K. Farber, D. Markovic, G. Kronenberg, K. Herrmann, J. Schnermann, C. Nolte, N. van Rooijen, J. Kiwit, et al.
A1 Adenosine Receptors in Microglia Control Glioblastoma-Host Interaction.
Cancer Res.,
September 1, 2006;
66(17):
8550 - 8557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Teng, H. R. Ansari, P. J. Oldenburg, J. Schnermann, and S. J. Mustafa
Isolation and characterization of coronary endothelial and smooth muscle cells from A1 adenosine receptor-knockout mice
Am J Physiol Heart Circ Physiol,
April 1, 2006;
290(4):
H1713 - H1720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Noorbakhsh, S. Tsutsui, N. Vergnolle, L. A. Boven, N. Shariat, M. Vodjgani, K. G. Warren, P. Andrade-Gordon, M. D. Hollenberg, and C. Power
Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis
J. Exp. Med.,
February 21, 2006;
203(2):
425 - 435.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Chunn, J. G. Molina, T. Mi, Y. Xia, R. E. Kellems, and M. R. Blackburn
Adenosine-Dependent Pulmonary Fibrosis in Adenosine Deaminase-Deficient Mice
J. Immunol.,
August 1, 2005;
175(3):
1937 - 1946.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. F. Liu and Y. H. Wong
G16-mediated Activation of Nuclear Factor {kappa}B by the Adenosine A1 Receptor Involves c-Src, Protein Kinase C, and ERK Signaling
J. Biol. Chem.,
December 17, 2004;
279(51):
53196 - 53204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Thomas, P. D. Walker, J. A. Benjamins, T. J. Geddes, and D. M. Kuhn
Methamphetamine Neurotoxicity in Dopamine Nerve Endings of the Striatum Is Associated with Microglial Activation
J. Pharmacol. Exp. Ther.,
October 1, 2004;
311(1):
1 - 7.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|